Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAPPHIRE: Amenamevir in immunosuppressed patients with herpes zoster
jRCTs031190208Completed
- Sponsor
- Maruho Co., Ltd.
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of Amenamevir in herpes zoster (HZ), sponsored by Maruho Co., Ltd. Primary endpoint: Overall improvement of skin symptoms at Day 7. Started Apr 2020; status: completed.
02
Drugs
Amenamevir
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on jRCTs031190208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031190208.